According to current classifications, one of which is given below, thrombocytopathy divided into hereditary (Congenital) and acquired (symptomatic), with both the first, and when Second prevails petechial-spotted type of bleeding, inferiority is revealed microcirculatory hemostasis.
Overwhelming Most thrombocytopathy characterized by various disturbances aggregation of platelets (when deployed forms - all or most aggregating agents, with partial - to separate them from), that may be associated with a deficit of membrane glycoproteins, is a receptor for aggregating agents (Glanzmann thrombasthenia, trombotsitodistrofiya, or illness Bernard - Soulier, Wiskott-Aldrich syndrome, and others.), and violation release of dense granules or absence (storage pool disease), COX deficiency, thromboxane and other enzymes, or blocking them from outside (acetylsalicylic acid and other drugs), violation of calcium transport and function of cells of the contractile apparatus. Less common isolated factor deficiency 3 platelets - clotting lipid matrix.
These major violations can be combined with a constant or intermittent thrombocytopenia (trombotsitodistrofiya, syndromes Mey - Hegglina, Viskotta - Aldrich, syndrome absence radius et al.), dramatic increase (to 7- 9 m) diameter of platelets (trombotsitodistrofiya, May's syndrome - Hegglina) or, opposite, its decrease (Wiskott - Aldrich).
Ristomitsin-aggregation impaired in angiogemofilii (von Willebrand disease) due to lack of the appropriate factor in the plasma and trombotsitodistrofii due to lack of platelet membrane receptors to this factor, content in normal plasma.
Thrombocytopathy often associated with immune disorders (Wiskott - Aldrich, Chediak - Higashi et al.), bone dysplasias, ligaments, total or partial lack of pigmentation (albinism) and other pathology.
Hereditary forms
Acquired (symptomatic) shape
The table lists the criteria for the differential diagnosis of a number of typical laboratory parameters thrombocytopathy, representing each of the groups listed in the labeling of this pathology. The table also includes hemophilia A because of its similarity to a number of parameters angiohemophilia (von Willebrand's disease).
|
Basic differential diagnostic criteria thrombocytopathy |
|||||||
|
Criteria |
Glanzmann thrombasthenia |
Aspirin-like syndrome |
Syndrome Herzhmanskogo-Pudlaka |
Gray platelet syndrome |
Trombotsitodistrofiya (Bernard-Soulier syndrome) |
Angiogemofilija (von Willebrand disease) |
Hemophilia A |
| Type of bleeding | Petechial-spotted | Petechial-spotted | Mixed | Normal | |||
| Bleeding time | Normally increased | Promoted | In normal or reduced | Reduced | Normal | Normal | |
| Number of platelets | In normal or reduced | Normal | Normal | In normal or reduced | Reduced | Normal | Normal |
| Dimensions of platelets | Normal | Normal | Normal | Normal | Giant | Normal | Normal |
| Violation of retraction | + | – | – | – | – | – | – |
| Deficiency of dense granules | – | – | + | – | – | – | – |
| Deficiency of α-granules | – | – | – | + | – | – | – |
| Violation of aggregation | |||||||
| ADF, adrenaline: | |||||||
| The first phase | + | – | – | – | – | – | – |
| The second phase | + | + | + | + | – | – | – |
| Thrombin-aggregation | + | +- | + | +- | +- | – | – |
| Ristomitsin-aggregation | – | – | – | – | + | + | – |
| Reaction release | Normal | Disrupted | Disrupted | Disrupted | Normal | Normal | Normal |
| The synthesis of thromboxane A2 | Normal | Broken | In normal or reduced | Broken | Normal | Normal | Normal |
| The concentration of Factor VIII:FROM | Normal | Normal | Normal | Normal | Normal | Most reduced | Significantly reduced |
| The concentration of Factor VIII:PKOF, VIII: AG | Normal | Normal | Normal | Normal | Normal | Reduced | Normal |
| The concentration of the von Willebrand factor in blood plasma | Normal | Normal | Normal | Normal | Normal | Reduced | Normal |
| Deficiency of membrane lipoproteins | + | – | – | – | + | – | – |
| Note: (+) – наличие соответствующего признака; (-)-no sign; (+-) - The presence of non-permanent feature | |||||||
The most difficult diagnostics angiohemophilia (von Willebrand disease), since in recent literature describes a number of its variants, differing from each other in the pathogenesis, the type of abnormality of von Willebrand factor, and so on. d. Significant signs of the disease causes a variety of suspect, what, perhaps, in this case, there is not one disease, but a group.
The table shows the characteristics of violations, inherent in the various options angiohemophilia.
|
Characteristics of the main types angiohemophilia (von Willebrand disease) |
|||||||||
| Indicators | I type | II type | III type | IV type | Psevdobolezn Willebrand (platelet form) | ||||
| I.1 | I.2 | I.3 | IIA | IIB | IIC | ||||
| Bleeding time | Promoted | Promoted | Promoted | Increased or slightly increased | Promoted | ||||
| The level of factor VIII:FROM | Lowered | Lowered | Lowered | In normal or reduced | Normal | Lowered | Normal | ||
| The level of von Willebrand factor VIII:PKOF | Lowered | Lowered | Lowered | Lowered | Normal | Lowered | Decreased or normal | Lowered | Povыshena P-aggregation |
| The level of factor VIII:Cardiovascular | |||||||||
| The blood plasma | Lowered | Lowered | Normal | Almost OK | Almost OK | Almost OK | Lowered | Lowered | Normal |
| The platelets | Lowered | Normal | Lowered | Almost OK | Normal | Almost OK | – | Lowered | Lowered (combined with passing thrombocytopenia) |
| Multimeric structure of von Willebrand factor | Normal | Normal | Normal | Broken blood plasma and platelets | Disturbed only in blood plasma | Broken blood plasma and platelets | – | – | Disrupted platelets (in conjunction with the violation of platelet von Willebrand factor adsorption due to a defect of platelets) |
In clinical practice, the most frequent two varieties angiohemophilia - I type (about 70 % cases) and IIA type (10-12 % cases) .
These forms are characterized by identical violations and differ only in the level of antigen, bound to vWF. They should be differentiated type IIB, which is easily distinguished by increased ristomycin aggregation at a reduced activity of von Willebrand factor in the blood plasma, and von Willebrand psevdobolezn, whereby increased ristomycin-aggregation combined with normal plasma vWF and its antigen. For type IV characteristic of normal time aigiogemofilii capillary bleeding.
In von Willebrand disease transfusion of fresh frozen plasma and cryoprecipitate enhance the activity of factor VII:C for a longer period, than in hemophilia A and B at the same time improve ristomycin-cofactor activity.
Quantitative determination of the activity of the von Willebrand factor - Available technique, giving a much more accurate information, than the definition ristomycin-cofactor activity of blood plasma, which often does not reveal a moderate decline (to 35-50 % norms) von Willebrand factor. Meanwhile, such a decrease is observed in a sufficiently large number of people with angiohemophilia. Given the high incidence of the disease, apparently, need for more widespread adoption of this technique in practice. This laboratory is able to identify and increase of plasma levels of von Willebrand factor, that it is important to determine the extent of damage of the endothelium in many vascular diseases (vasculitis, atherosclerosis and others.), and to identify thrombophilia.
According to current classifications, one of which is given below, thrombocytopathy divided into hereditary (Congenital) and acquired (symptomatic), with both the first, and in the second it prevails petechial-spotted type of bleeding, inferiority is revealed microcirculatory hemostasis.
This site uses cookies and services to collect technical data from visitors to ensure performance and improve the quality of service.. By continuing to use our site, you automatically agree to the use of these technologies.
Read More